Expand JANX Menu
JANX MENU

JANX Stock Posts


Unusual Option Volume

JANX Janux Therapeutics15.08+1.81 (+13.6%)

Janux Therapeutics trades 3,576 contracts. News: Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors
View Details...
Unusual Option Volume

JANX Janux Therapeutics16.78+0.92 (+5.8%)

Janux Therapeutics trades 2,363 contracts.
View Details...
Unusual Option Volume

JANX Janux Therapeutics17.33-16.66 (-49.0%)

Janux Therapeutics trades 5,217 contracts. News: Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC
View Details...
JANX #JanuxTherapeutics stock declines -44.2% in after hours trading. See the latest news.

After Hours Decliner

JANX Janux Therapeutics33.99-0.10-0.3%

After Hours:18.95-15.04 (-44.3%)

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

Business WireMon, 1-Dec 4:05 PM
Unusual Option Volume

JANX Janux Therapeutics33.06-1.03 (-3.0%)

Janux Therapeutics trades 2,802 contracts. The company has the following event: Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC on Dec 1, 2025.
View Details...
Unusual Option Volume

JANX Janux Therapeutics34.93+0.19 (+0.6%)

Janux Therapeutics trades 2,865 contracts. The company has the following event: Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC on Dec 1, 2025.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes